About 50% of chromosome region 2q21-q31 deletions are associated with seizures, and the band 2q24 is the smallest commonly deleted segment in these patients (Davidsson et al., 2008) . Previous publications showed that deletions of the voltage-gated sodium channel cluster at 2q24 (SCN cluster), and point mutations in one of these genes, SCN1A, are associated with severe myoclonic epilepsy of infancy/ Dravet syndrome (DS -MIM 607208).
Array comparative genomic hybridization (Array-CGH) is a powerful tool for causally associating genomic imbalances to particular phenotypes (Vissers et al., 2004; Rosenberg et al., 2006; Cheroki et al., 2008; Knijnenburg et al., 2009 ). Herein we describe three patients with overlapping deletions at 2q24, investigated by array-CGH: one of them had Dravet syndrome, another presented a milder and lateonset form of epilepsy, and a third one did not manifest epilepsy up to the age of 5 years. Mapping the deletions led to the identification of a chromosome segment associated with epilepsy in addition to the SCN cluster.
Patients
The patients were originally investigated by array-CGH for presenting syndromic mental impairment. Patients 1 and 3 were investigated at the University of S¼o Paulo (Brazil) . Patient 2 was investigated at the Leiden University Medical Center (University of Leiden, The Netherlands), and exhibited a deletion derived from a t(2;8)(q31;p21.3). Data on the patients were deposited in the DECIPHER database (http://www.decipher. sanger.ac.uk).
Patient 1 (DECIPHER USP00004570)
This 14-year-old female patient weighed 2,240 g at birth (P <3rd) with an occipitofrontal circumference (OFC) of 31 cm (P <3rd). Milestones were delayed: she sat without support at 18 months of age, walked at 4 years, and has never talked. Epilepsy started at 10 years of age, with recurrent tonic generalized seizures during sleep (2-3 times a week, in clusters of up to five seizures a day). Physical examination disclosed microcephaly (OFC 52 cm, P <2.5nd), short stature (144 cm, P <2.5nd), and centripetal obesity (64 kg, P <50-75th). She had small feet and hands, and tapered fingers. Her gait was ataxic and wide-based, and was performed with straighten legs. The patient had valgus feet and abduction of upper limbs, reminiscent of Angelman syndrome. She was mentally retarded and presented autistic features, including hyperactivity, stereotyped hand movements, lack of eye contact, and strong attachment to objects. Molecular investigation excluded Angelman syndrome. Screening for inborn errors of metabolism and brain magnetic resonance imaging (MRI) showed no abnormalities. Electroencephalography (EEG), performed at 10 years of age, disclosed multifocal bursts of spikes, which were more intense in the temporal-occipital region.
Patient 2 (DECIPHER LEI00001576)
This patient was born at 38 weeks of gestation after an intrauterine insemination-induced pregnancy, with a birth weight of 3,420 g. At 7 months she had surgery because of a tied-tongue. Although her motor milestones were reached at the appropriate times, she had coordination problems. She was referred because of speech problems and digital anomalies. She had never manifested epileptic seizures. On examination at 5 years and 8 months her height was 1.27 m (P >97th), weight 33 kg (P >97th), and OFC 53.5 cm (P 50-98th). She spoke with a lisp. She had truncal obesity and subtle dysmorphic features: hypotelorism; down-slanted, short, and narrow palpebral fissures; almond-shaped eyes; full cheeks; long philtrum; simple ears; tapered fingers with clinodactyly of the fifth fingers; broad feet with sandal gaps; and small third toes. She had generalized joint hyperlaxity. X-ray of the hands showed shortening of the middle phalanx of the fifth fingers and a dysplastic third metacarpal bone on the left.
Patient 3 (DECIPHER USP00001452)
This patient, a 5-year-old girl, was born postterm (43 weeks) by C-section, and with an Apgar score of 7/8. Her birth weight was 3,500 g (P 50th) and length 50.5 cm (P 50-75th). Newborn screening disclosed hypothyroidism, and hormone replacement was started at 2 months of age. Due to swallowing difficulties, she had recurrent pulmonary infections, and at 11 months of age, a G-tube was placed. She had severe and untreatable epilepsy commencing at 2 months of age with a febrile prolonged seizure. Subsequently, she presented epileptic seizures with fever for at least once a week. Several different types of epileptic seizure were reported: absences, generalized tonic during sleep, myoclonic, atypical absence, and epileptic spasms. Epilepsy was refractory to several antiepileptic drugs (AEDs), used alone or in association. Currently she has profound mental retardation and her performance on the Denver Developmental Scale is below 3 months of age. She makes no eye contact, cannot hold up her head, and is moderately hypotonic. Physical examination showed micro/brachycephaly (OFC 45 cm, P <2.5nd) and dysmorphic facial features, including thin nose with depressed and broad nasal bridge, anteverted nares, and short philtrum. Additional findings were tapered fingers and anteriorly displaced anus. Ophthalmologic evaluation disclosed left eye iris coloboma, right eye choroid, and retina coloboma. Brain MRI performed at 6 months of age was normal, and neck ultrasound showed agenesis of the right thyroid lobe. Electroencephalography performed at 5 years disclosed profound diffuse disorganization of cerebral electrical activity and frequent bursts of multifocal spikes and slow waves. Several electrographic and clinical seizures were registered: they were characterized either by episodes of generalized rhythmic theta or rapid activity accompanied by eye staring and unresponsiveness or without demonstrable clinical features. Marked photosensitivity in all frequencies was also present.
Methods

Array-CGH
Patients were screened by 1 Mb BAC array-CGH, as described previously (Rosenberg et al., 2006) . The investigation disclosed three different deletions at 2q24. Fluorescence in situ hybridization (FISH) on metaphases from the patients and their parents confirmed the deletions in the patients, and demonstrated that they were de novo. To further map the deletions, we performed oligonucleotide array-CGH using a 4x44K whole-genome platform (NGRL Wessex Constitutional Array, design 017457; Agilent Technologies, Santa Clara, CA, U.S.A.), hybridized according to the manufacturer's protocols. Scanned images of the arrays were processed and analyzed using Feature Extraction and DNA Analytics (both from Agilent Technologies).
Results
The genomic coordinates of the deletions are described in Table 1 . Patient 2, who has a translocation cytogenetically defined as t(2;8)(q31;p21.3), was not found to carry any other genomic imbalance in addition to the 2q microdeletion. Fig. 1 depicts the mapping of the 2q24 deletions, and the genes in this region. The segment comprising the three deletions spans 11 Mb. The breakpoints were unique for each of the three deletions, but they shared an overlapping segment of approximately 590 Kb at 2q24.2. Although scattered copy number variants within this region are documented in the Database of Genomic Variants (http://projects.tcag.ca/ variation), they cover only a minor part of the deletion containing segment described here.
Discussion
We describe three different deletions in a segment spanning 11 Mb on a region of chromosome 2 previously implicated in epilepsy. Patient 1 had a mild and late-onset form of epilepsy, associated with autistic features. She carried the most proximal deletion at 2q24, which did not include the SCN cluster, demonstrating the presence of another gene predisposing to seizures. Patient 2 had the smallest deletion, completely overlapped by the two other rearrangements. Because she is so far seizure-negative, there is no evidence as yet that genes involved with epilepsy have been affected; however, this patient is only 5 years old, and may still manifest a later form of epilepsy, similar to patient 1, who started (Madia et al., 2006; Moller et al., 2008; Wang et al., 2008) . Although patient 1 was seizure-positive, her deletion did not include the SCN cluster. The best candidate gene for epilepsy in this patient is SLC4A10, a sodium bicarbonate transporter gene that plays an important role in regulating intracellular pH (Jacobs et al., 2008) , and is highly expressed in mice cerebral cortex and hippocampus. SLC4A10 was recently reported to be disrupted in a balanced reciprocal translocation t(2;13)(q24;q31) in a patient with seizures and mental impairment (Gurnett et al., 2008) , and was also found to be partially deleted in a case of autism (Sebat et al., 2007) . The SLC4A10 gene is also deleted in patient 3, and haploinsufficiency for this gene might have added to the severity of her phenotype. However, none of the 2q24 deletions previously investigated at molecular level (Davidsson et al., 2008; Marini et al., 2009 ) included SLC4A10 and, therefore, conclusions regarding the severity of the phenotype associated with deletions involving both the SLC4A10 and SCN1A genes require further verification.
In conclusion, our findings show that deletion of a segment proximal but adjacent to the SCN cluster is associated with seizures and autistic features, consistent with haploinsufficiency of the SLC4A10 gene. The seizure pattern caused by this deletion appears clinically distinct and less severe than Dravet syndrome.
